Orphazyme A/S buy Amped
Start price
23.06.21
/
0%
€6.90
Target price
21.06.22
-
Performance (%)
-1.45%
End price
25.06.21
€6.80
Summary
This prediction ended on 25.06.21 with a price of €6.80. With a performance of -1.45%, the BUY prediction for Orphazyme A/S by Amped closed slightly in the red. This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Orphazyme A/S | - | - | - | - |
iShares Core DAX® | 1.518% | 3.456% | 25.970% | 21.597% |
iShares Nasdaq 100 | 1.240% | 2.983% | 31.325% | 39.177% |
iShares Nikkei 225® | 2.808% | 2.743% | 19.597% | 5.115% |
iShares S&P 500 | 0.403% | 2.187% | 28.624% | 40.348% |
According to Amped what are the pros and cons of Orphazyme A/S for the foreseeable future?
Pros
EBIT growth >5% per year expected
Capable Management
Known brand
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Good culture
Sustainability is important
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Few uniques
Dependend from some customers or products
Significant cyclical dependencies
Comments by Amped for this prediction
In the thread Orphazyme A/s diskutieren
Buy Orphazyme A/S
In the thread Trading Orphazyme A/s
Buy beendet
Stopped prediction by Amped for Orphazyme A/S
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.80
25.06.21
25.06.21
-
21.06.22
21.06.22
-88.60%
22.06.22
22.06.22
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€0.78
25.06.21
25.06.21
-
21.06.22
21.06.22
-
25.06.21
25.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.30
21.06.21
21.06.21
-
21.06.22
21.06.22
9.52%
23.06.21
23.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.55
21.06.21
21.06.21
-
21.06.22
21.06.22
-3.82%
21.06.21
21.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products